TY - JOUR AU - MartinĂ³n Torres, Federico PY - 2012 SN - 1473-3099 UR - http://hdl.handle.net/20.500.11940/4914 LA - eng TI - Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: A randomised, single-blind, placebo-controlled, phase 2 trial DO - 10.1016/S1473-3099%2812%2970087-7 T2 - LANCET INFECTIOUS DISEASES M2 - 597 VL - 12 ER -